Navigation Links
Exergen Granted New Patent for Temporal Artery Thermometers
Date:3/17/2011

WATERTOWN, Mass., March 17, 2011 /PRNewswire/ -- A recently issued patent extends protection of the technology incorporated in Exergen's award winning and best selling medical thermometer brand, the TemporalScanner™ Temporal Artery Thermometers.  Exergen Corporation has recently been granted U.S. Patent No. 7,787,938, entitled, "Temporal Artery Temperature Detector" by the US Patent and Trademark Office, adding to the already extensive Exergen portfolio of valuable intellectual property rights that it has developed for its non-invasive thermometry products.

With 15 US Patents protecting the TemporalScanner professional versions, and 10 US Patents protecting the home model, Exergen continues to vigorously defend its intellectual property rights.  It has brought a number of lawsuits over the years to successfully stop companies from infringing upon Exergen's rights with regard to infrared temperature measuring products. Currently Exergen has brought suit against Kidz-Med, Inc., American Scientific Resources, Inc. and Tecnimed S.R.L for patent infringement in the United States District Court for the District of Massachusetts.

"This new patent confirms and protects important innovations in non-invasive thermometry contained in our Temporal Artery Thermometers," said Dr. Francesco Pompei, Exergen CEO and inventor of the patented technology.  "These innovations are central to the overwhelming success of the temporal artery method, which many competitors would like to use.  As a U.S. manufacturer we rely on strong patent protection to protect our rights, and do our part to help protect the spirit of innovation in a highly competitive world."

Exergen Corporation is recognized worldwide as an innovator and leading manufacturer of patented infrared thermometers, scanners, sensors and controls.  Its products are used in a wide variety of industrial and medical applications for both professionals and consumers.  Its TemporalScanner medical thermometers are responsible for nearly a billion temperatures taken per year in thousands of hospitals and clinics.  Its home model is used in more than 3 million homes and is the #1 selling retail brand. For additional information, visit www.exergen.com.


'/>"/>
SOURCE Exergen Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Exergen TemporalScanner Effective in Detecting Fevers in Children Aged 1-4 Years, Study Finds
2. Exergen TemporalScanner Thermometer Best Selling Brand at Retailers
3. Exergen TemporalScanner Sponsors Game Time Temperature for NFL and College Bowl Games
4. Exergen Game Time Temperature Contest Helps Football Fans Tackle Cold and Flu Season
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Hodgkins Lymphoma
7. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
8. Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery
9. Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA
10. Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency
11. Emphasys Medical Granted Expedited Review From FDA for Zephyr(R) Endobronchial Valve
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):